Trade RLAY anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Relay Therapeutics, Inc. (RLAY) is trading at US$19.04, up 0.16% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$4.26B. Over the past 52 weeks, RLAY has traded between US$3.87 and US$21.27. On Syfe you can trade RLAY with $0 commission and add it to your watchlist.
| Previous close | US$19.01 |
|---|---|
| Market cap | US$4.26B |
| 52-week range | US$3.87 – US$21.27 |
| Volume | 2.05M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Year: 2020
-- Earnings Flash (RLAY) Relay Therapeutics Posts Q2 Loss $0.41 per Share, vs. FactSet Est of $0.39 Loss
Aug 6, 9:38 PM · MT Newswires
-- Earnings Flash (RLAY) Relay Therapeutics, Inc. Reports Q2 Revenue $400,000
Aug 6, 8:21 PM · MT Newswires
Canaccord Genuity Initiates Relay Therapeutics at Buy With $29 Price Target
Jul 16, 11:38 AM · MT Newswires
Relay Therapeutics, Inc. (RLAY) stock is trading at US$19.04, +0.16% from the previous close of US$19.01.
The market cap for Relay Therapeutics, Inc. (RLAY) stock is approximately US$4.26B.
The 52-week high for Relay Therapeutics, Inc. (RLAY) stock is US$21.27.
The 52-week low for Relay Therapeutics, Inc. (RLAY) stock is US$3.87.
Relay Therapeutics, Inc. (RLAY) does not currently pay a dividend.
Stay on top of RLAY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
